Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,450
Total Claims
$661K
Drug Cost
932
Beneficiaries
$709
Cost/Patient
Risk Score Breakdown 41/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+499%
Opioid rate vs peers
55.0% vs 9.2% avg
-1%
Cost per patient vs peers
$709 vs $719 avg
+5%
Brand preference vs peers
7.0% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid rate is 499% above Physician Assistant peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
55.0%
Opioid Rate
5,202
Opioid Claims
$395K
Opioid Cost
19.5%
Long-Acting Rate
This provider's opioid prescribing rate of 55.0% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 658 claims · $360K
Generic: 8,792 claims · $301K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Buprenorphine Hcl | 83 | $76K |
| Buprenorphine | 183 | $57K |
| Hydrocodone/Acetaminophen | 1,386 | $40K |
| Oxycodone Myristate | 62 | $39K |
| Oxycodone Hcl | 65 | $36K |
| Oxycodone Hcl | 1,356 | $33K |
| Oxycodone Hcl/Acetaminophen | 851 | $31K |
| Erenumab-Aooe | 15 | $29K |
| Linaclotide | 44 | $25K |
| Diclofenac Sodium | 270 | $21K |
| Pregabalin | 352 | $21K |
| Gabapentin | 1,092 | $19K |
| Buprenorphine | 18 | $18K |
| Lidocaine | 131 | $16K |
| Tapentadol Hcl | 27 | $15K |
Prescribing Profile
47
Unique Drugs
41.0
Anomaly Score
Patient Profile
66
Avg Age
63%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About